Drug Yields High Response Rates for Lung Cancer Patients with Harsh Mutation
University of Texas MD Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program™ at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries a highly treatment-resistant mutation.